Literature DB >> 21768186

Subjective and functional deterioration in recurrences of neovascular AMD are often preceded by morphologic changes in optic coherence tomography.

Robert Hoerster1, Philipp S Muether, Manuel M Hermann, Konrad Koch, Bernd Kirchhof, Sascha Fauser.   

Abstract

BACKGROUND: Different tests were applied to test the sensitivity of patient self-control; Amsler grid and visual acuity (VA) assessment, as well as fundus examinations to reveal recurrent choroidal neovascularisation (CNV) activity in age-related macular degeneration as detected by spectral domain optical coherence tomography (SD-OCT) in monthly controls.
METHODS: A prospective interventional case series of patients with exudative age-related macular degeneration was examined, which received ranibizumab injections until complete resolution of fluid in SD-OCT. Analysis of changes in subjective perception, Amsler grid, early treatment diabetic retinopathy study (ETDRS) VA, Radner reading VA and fundus examination was conducted in the case of OCT-confirmed CNV recurrences.
RESULTS: Out of 40 morphological recurrences determined by SD-OCT, six (15%) were noticed by subjective patient perception. Amsler grid testing revealed deterioration in 12 cases (30%); 11 recurrences (28%) were accompanied by loss of ≥5 letters in ETDRS VA and/or ≥ 1 line in Radner VA; fundus examination showed signs of novel CNV activity in 10 out of 40 recurrences (25%). The combined sensitivity of all diagnostic methods compared to SD-OCT for recurrence detection was 67.5% (27 out of 40 recurrences).
CONCLUSION: Subjective patient perception, Amsler grid, VA as well as fundus examination lead to pronounced underestimations of CNV recurrences. Morphologic recurrences can be detected prior to functional deterioration. As any delay of treatment can result in irreversible vision loss, attempts should be made to provide monthly OCT controls to detect recurrences as early as possible.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21768186     DOI: 10.1136/bjo.2010.201129

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  10 in total

1.  Temporal pattern of resolution/recurrence of choroidal neovascularization during bevacizumab therapy for wet age-related macular degeneration.

Authors:  Haiyan Wang; Giulio Barteselli; William R Freeman; Su Na Lee; Jay Chhablani; Sharif El-Emam; Lingyun Cheng
Journal:  Int J Ophthalmol       Date:  2013-10-18       Impact factor: 1.779

2.  Subjective evaluation of visual acuity is not reliable to detect disease activity in different exudative maculopathies.

Authors:  Marie-Christine Bruender; Nicola Benjamin; Hansjuergen Thomas Agostini; Andreas Stahl; Christoph Ehlken
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-01       Impact factor: 3.117

3.  [Anti-VEGF therapy for neovascular age-related macular degeneration -therapeutic strategies: statement of the German Ophthalmological Society, the German Retina Society and the Professional Association of Ophthalmologists in Germany - November 2014].

Authors: 
Journal:  Ophthalmologe       Date:  2015-03       Impact factor: 1.059

Review 4.  Statement of the German Ophthalmological Society (DOG), the German Retina Society (GRS), and the Professional Association of German Ophthalmologists (BVA) on anti-VEGF treatment in neovascular age-related macular degeneration : Status February 2020.

Authors: 
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

5.  [Clinical parameters of patients with neovascular age-related macular degeneration : Longterm treatment results of an outpatient clinic].

Authors:  S Wassel; E Tsompanidi; E Tahmaz; B Hörster; R Hoerster
Journal:  Ophthalmologe       Date:  2019-05       Impact factor: 1.059

6.  Self-Examination Low-Cost Full-Field Optical Coherence Tomography (SELFF-OCT) for neovascular age-related macular degeneration: a cross-sectional diagnostic accuracy study.

Authors:  Claus von der Burchard; Helge Sudkamp; Jan Tode; Cristoph Ehlken; Konstantine Purtskhvanidze; Moritz Moltmann; Britta Heimes; Peter Koch; Michael Münst; Malte Vom Endt; Timo Kepp; Dirk Theisen-Kunde; Inke König; Gereon Hüttmann; Johann Roider
Journal:  BMJ Open       Date:  2022-06-27       Impact factor: 3.006

7.  Aqueous vascular endothelial growth factor and ranibizumab concentrations after monthly and bimonthly intravitreal injections of ranibizumab for age-related macular degeneration.

Authors:  Xiying Wang; Tomoko Sawada; Masashi Kakinoki; Taichiro Miyake; Hajime Kawamura; Yoshitsugu Saishin; Ping Liu; Masahito Ohji
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-07       Impact factor: 3.117

8.  [Visual acuity in anti-VEGF therapy for AMD : Can specific characteristics in the SD-OCT help?]

Authors:  B Book; M Ziegler; B Heimes; M Gutfleisch; G Spital; D Pauleikhoff; A Lommatzsch
Journal:  Ophthalmologe       Date:  2017-01       Impact factor: 1.059

9.  Optical coherence tomography findings in patients prior to cataract surgery regarded as unremarkable with ophthalmoscopy.

Authors:  Antonia Kowallick; Charlotte Viola Fischer; Hans Hoerauf
Journal:  PLoS One       Date:  2018-12-11       Impact factor: 3.240

10.  Optical coherence tomography angiography in exudative age-related macular degeneration: a predictive model for treatment decisions.

Authors:  Florence Coscas; Marco Lupidi; Jean François Boulet; Alexandre Sellam; Diogo Cabral; Rita Serra; Catherine Français; Eric H Souied; Gabriel Coscas
Journal:  Br J Ophthalmol       Date:  2018-11-22       Impact factor: 4.638

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.